14May 2021
Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the SGLT2 inhibitor, tofogliflozin

Association of estimated plasma volume and weight loss after long‐term administration and subsequent discontinuation of the SGLT2 inhibitor, tofogliflozin

Sodium/glucose‐cotransporter 2 inhibitors (SGLT2is) are drugs that have been reported to have several effects through the regulation of plasma volume such as antihypertensive effects, etc. This study aimed to clarify the impact of long‐term administration and subsequent discontinuation of the SGLT2i tofogliflozin on estimated plasma volume (ePV), brain natriuretic peptide (BNP) and the relationship between changes in ePV, BNP and body weight (BW)...

  • #endo-diabetology

Like

Save

Share